Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" What do we do for the very old?
Sealy Center on Aging, UTMB D-60, 301 University Blvd., Galveston, TX 77555-0460, USA. jsgoodwi@utmb.edu
James S
JS
Goodwin
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000517:prevention & control*; D008875:Middle Aged; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors